177 related articles for article (PubMed ID: 38751629)
1. Small Molecule Functional Converter of B-Cell Lymphoma-2 (Bcl-2) Suppresses Breast Cancer Lung Metastasis.
Kopparapu PR; Löhr CV; Pearce MC; Tyavanagimatt S; Nakshatri H; Kolluri SK
ACS Pharmacol Transl Sci; 2024 May; 7(5):1302-1309. PubMed ID: 38751629
[TBL] [Abstract][Full Text] [Related]
2. Identification and Characterization of a Small Molecule Bcl-2 Functional Converter.
Kopparapu PR; Pearce MC; Löhr CV; Duong C; Jang HS; Tyavanagimatt S; O'Donnell EF; Nakshatri H; Kolluri SK
Cancer Res Commun; 2024 Mar; 4(3):634-644. PubMed ID: 38329389
[TBL] [Abstract][Full Text] [Related]
3. B-cell lymphoma-2 family proteins in the crosshairs: Small molecule inhibitors and activators for cancer therapy.
Gong Q; Wang H; Zhou M; Zhou L; Wang R; Li Y
Med Res Rev; 2024 Mar; 44(2):707-737. PubMed ID: 37983840
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway.
Imanishi Y; Hu B; Xiao G; Yao X; Cheng SY
J Biol Chem; 2011 Aug; 286(33):29249-29260. PubMed ID: 21680733
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of apoptosis in human breast cancer cells: role in tumor progression to the metastatic state.
Fernández Y; Gu B; Martínez A; Torregrosa A; Sierra A
Int J Cancer; 2002 Oct; 101(4):317-26. PubMed ID: 12209955
[TBL] [Abstract][Full Text] [Related]
6. Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade.
Williams MM; Lee L; Hicks DJ; Joly MM; Elion D; Rahman B; McKernan C; Sanchez V; Balko JM; Stricker T; Estrada MV; Cook RS
Mol Cancer Res; 2017 Mar; 15(3):259-268. PubMed ID: 28039357
[TBL] [Abstract][Full Text] [Related]
7. CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth.
Lin Y; Zhao Y; Chen M; Li Z; Liu Q; Chen J; Ding Y; Ding C; Ding Y; Qi C; Zheng L; Li J; Zhang R; Zhou J; Wang L; Zhang QQ
BMC Cancer; 2023 May; 23(1):479. PubMed ID: 37237269
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-148a promotes apoptosis and suppresses growth of breast cancer cells by targeting B-cell lymphoma 2.
Li Q; Ren P; Shi P; Chen Y; Xiang F; Zhang L; Wang J; Lv Q; Xie M
Anticancer Drugs; 2017 Jul; 28(6):588-595. PubMed ID: 28430743
[TBL] [Abstract][Full Text] [Related]
9. Bcl-3 promotes multi-modal tumour cell migration via NF-κB1 mediated regulation of Cdc42.
Turnham DJ; Yang WW; Davies J; Varnava A; Ridley AJ; Conlan RS; Clarkson RWE
Carcinogenesis; 2020 Oct; 41(10):1432-1443. PubMed ID: 31957805
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids.
Yang TM; Barbone D; Fennell DA; Broaddus VC
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):14-23. PubMed ID: 19097992
[TBL] [Abstract][Full Text] [Related]
11. B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy.
Alam M; Ali S; Mohammad T; Hasan GM; Yadav DK; Hassan MI
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638779
[TBL] [Abstract][Full Text] [Related]
12. BCL-W has a fundamental role in B cell survival and lymphomagenesis.
Adams CM; Kim AS; Mitra R; Choi JK; Gong JZ; Eischen CM
J Clin Invest; 2017 Feb; 127(2):635-650. PubMed ID: 28094768
[TBL] [Abstract][Full Text] [Related]
13. Cross Talk Between Cellular Redox State and the Antiapoptotic Protein Bcl-2.
Pohl SÖ; Agostino M; Dharmarajan A; Pervaiz S
Antioxid Redox Signal; 2018 Nov; 29(13):1215-1236. PubMed ID: 29304561
[TBL] [Abstract][Full Text] [Related]
14. Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.
Coloff JL; Macintyre AN; Nichols AG; Liu T; Gallo CA; Plas DR; Rathmell JC
Cancer Res; 2011 Aug; 71(15):5204-13. PubMed ID: 21670080
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation.
Anderson GR; Wardell SE; Cakir M; Crawford L; Leeds JC; Nussbaum DP; Shankar PS; Soderquist RS; Stein EM; Tingley JP; Winter PS; Zieser-Misenheimer EK; Alley HM; Yllanes A; Haney V; Blackwell KL; McCall SJ; McDonnell DP; Wood KC
Sci Transl Med; 2016 Dec; 8(369):369ra175. PubMed ID: 27974663
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2.
Real PJ; Cao Y; Wang R; Nikolovska-Coleska Z; Sanz-Ortiz J; Wang S; Fernandez-Luna JL
Cancer Res; 2004 Nov; 64(21):7947-53. PubMed ID: 15520201
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 Family Members Bcl-xL and Bax Cooperatively Contribute to Bortezomib Resistance in Mantle Cell Lymphoma.
Luanpitpong S; Janan M; Yosudjai J; Poohadsuan J; Chanvorachote P; Issaragrisil S
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430955
[TBL] [Abstract][Full Text] [Related]
18. Metastatic behavior of human breast carcinomas overexpressing the Bcl-x(L) gene: a role in dormancy and organospecificity.
Rubio N; España L; Fernández Y; Blanco J; Sierra A
Lab Invest; 2001 May; 81(5):725-34. PubMed ID: 11351044
[TBL] [Abstract][Full Text] [Related]
19. Anti-Metastatic Effect of Dehydrocorydaline on H1299 Non-Small Cell Lung Carcinoma Cells via Inhibition of Matrix Metalloproteinases and B Cell Lymphoma 2.
Lee J; Sohn EJ; Yoon SW; Kim CG; Lee S; Kim JY; Baek N; Kim SH
Phytother Res; 2017 Mar; 31(3):441-448. PubMed ID: 28144994
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737.
Kutuk O; Letai A
Cancer Res; 2008 Oct; 68(19):7985-94. PubMed ID: 18829556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
